The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. Various strategies are employed enhance antibody titer, comprising process parameter optimization, genetic engineering, and implementation of perfusion systems. Fine-tuning media composition plays